Eric P. Krenning

33.9k total citations · 9 hit papers
277 papers, 22.6k citations indexed

About

Eric P. Krenning is a scholar working on Epidemiology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Eric P. Krenning has authored 277 papers receiving a total of 22.6k indexed citations (citations by other indexed papers that have themselves been cited), including 191 papers in Epidemiology, 153 papers in Oncology and 116 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Eric P. Krenning's work include Neuroendocrine Tumor Research Advances (187 papers), Lung Cancer Research Studies (124 papers) and Neuroblastoma Research and Treatments (95 papers). Eric P. Krenning is often cited by papers focused on Neuroendocrine Tumor Research Advances (187 papers), Lung Cancer Research Studies (124 papers) and Neuroblastoma Research and Treatments (95 papers). Eric P. Krenning collaborates with scholars based in Netherlands, United States and Greece. Eric P. Krenning's co-authors include Dik J. Kwekkeboom, Marion de Jong, Wouter W. de Herder, Roelf Valkema, Boen L.R. Kam, Jean–Claude Reubi, Jaap J.M. Teunissen, P.P.M. Kooij, Willem H. Bakker and Martijn van Essen and has published in prestigious journals such as New England Journal of Medicine, Circulation and Journal of Clinical Oncology.

In The Last Decade

Eric P. Krenning

275 papers receiving 22.0k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Gastroenteropancreatic neuroendocrine tumours

2008 1.2k citations Wouter W. de Herder, Eric P. Krenning et al. profile →
Treatment With the Radiolabeled Somatostatin Analog [ ¹⁷⁷ Lu-DOTA ⁰ ,Tyr ³ ]Octreotate: Toxicity, Efficacy, and Survival

2008 1.1k citations Dik J. Kwekkeboom, Wouter W. de Herder et al. Journal of Clinical Oncology profile →
The Role of Somatostatin and Its Analogs in the Diagnosis and Treatment of Tumors

1991 680 citations Eric P. Krenning, Jean–Claude Reubi et al. profile →
ENETS Consensus Guidelines for the Management of Patients with Liver and Other Distant Metastases from Neuroendocrine Neoplasms of Foregut, Midgut, Hindgut, and Unknown Primary

2012 616 citations Éric Baudin, Eric P. Krenning et al. Neuroendocrinology profile →
Radiolabeled Somatostatin Analog [¹⁷⁷Lu-DOTA⁰,Tyr³]Octreotate in Patients With Endocrine Gastroenteropancreatic Tumors

2005 517 citations Dik J. Kwekkeboom, Jaap J.M. Teunissen et al. Journal of Clinical Oncology profile →
Long-Term Efficacy, Survival, and Safety of [177Lu-DOTA0,Tyr3]octreotate in Patients with Gastroenteropancreatic and Bronchial Neuroendocrine Tumors

2017 416 citations Tessa Brabander, Wouter A. van der Zwan et al. Clinical Cancer Research profile →
Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factors

2014 328 citations Lisa Bodei, Chiara Maria Grana et al. European Journal of Nuclear Medicine and Molecular Imaging profile →
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological, Nuclear Medicine and Hybrid Imaging

2017 303 citations Anders Sundin, Rudolf Arnold et al. Neuroendocrinology profile →
Health-Related Quality of Life in Patients With Progressive Midgut Neuroendocrine Tumors Treated With ¹⁷⁷Lu-Dotatate in the Phase III NETTER-1 Trial

2018 272 citations Eric P. Krenning et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eric P. Krenning Netherlands	83	14.5k	12.5k	9.4k	6.9k	2.8k	277	22.6k
E. P. Krenning Netherlands	58	8.4k 0.6×	6.7k 0.5×	5.2k 0.6×	2.9k 0.4×	2.5k 0.9×	168	12.7k
Marion de Jong Netherlands	60	6.9k 0.5×	6.4k 0.5×	3.6k 0.4×	6.2k 0.9×	1.4k 0.5×	246	13.5k
Wouter W. de Herder Netherlands	78	16.0k 1.1×	13.0k 1.0×	10.7k 1.1×	2.0k 0.3×	6.9k 2.5×	411	24.0k
Kjell Öberg Sweden	78	20.6k 1.4×	18.2k 1.4×	14.5k 1.6×	857 0.1×	2.0k 0.7×	402	26.1k
Rodney J. Hicks Australia	78	3.5k 0.2×	7.7k 0.6×	3.2k 0.3×	11.3k 1.6×	948 0.3×	602	23.8k
Kathleen R. Lamborn United States	81	4.1k 0.3×	3.1k 0.2×	3.0k 0.3×	5.7k 0.8×	1.3k 0.5×	292	22.7k
Haley Gittleman United States	33	4.4k 0.3×	2.9k 0.2×	3.7k 0.4×	2.9k 0.4×	1.4k 0.5×	77	21.1k
Marc C. Chamberlain United States	66	4.0k 0.3×	4.1k 0.3×	4.2k 0.4×	3.0k 0.4×	587 0.2×	329	17.9k
Matthias Preusser Austria	69	3.2k 0.2×	6.5k 0.5×	2.6k 0.3×	1.9k 0.3×	905 0.3×	543	18.4k
Richard P. Baum Germany	59	5.7k 0.4×	6.7k 0.5×	3.7k 0.4×	6.3k 0.9×	632 0.2×	353	13.1k

Countries citing papers authored by Eric P. Krenning

Since Specialization

Citations

This map shows the geographic impact of Eric P. Krenning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric P. Krenning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric P. Krenning more than expected).

Fields of papers citing papers by Eric P. Krenning

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric P. Krenning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric P. Krenning. The network helps show where Eric P. Krenning may publish in the future.

Co-authorship network of co-authors of Eric P. Krenning

This figure shows the co-authorship network connecting the top 25 collaborators of Eric P. Krenning. A scholar is included among the top collaborators of Eric P. Krenning based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric P. Krenning. Eric P. Krenning is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bodei, Lisa, Marta Cremonesi, Mahila Ferrari, et al.. (2025). Dosimetry of [¹⁷⁷Lu]Lu-DOTATATE in Patients with Advanced Midgut Neuroendocrine Tumors: Results from a Substudy of the Phase III NETTER-1 Trial. Journal of Nuclear Medicine. 66(3). 449–456. 6 indexed citations

Nock, Berthold A., Oleg G. Chepurny, George Loudos, et al.. (2022). Nonpeptidic Z360-Analogs Tagged with Trivalent Radiometals as Anti-CCK2R Cancer Theranostic Agents: A Preclinical Study. Pharmaceutics. 14(3). 666–666. 6 indexed citations

Hicks, Rodney J., Clarisse Dromain, Wouter W. de Herder, et al.. (2021). ENETS standardized (synoptic) reporting for molecular imaging studies in neuroendocrine tumours. Journal of Neuroendocrinology. 34(3). e13040–e13040. 13 indexed citations

Sundin, Anders, Rudolf Arnold, Éric Baudin, et al.. (2017). ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological, Nuclear Medicine and Hybrid Imaging. Neuroendocrinology. 105(3). 212–244. 303 indexed citations breakdown →

Brabander, Tessa, Wouter A. van der Zwan, Jaap J.M. Teunissen, et al.. (2017). Long-Term Efficacy, Survival, and Safety of [177Lu-DOTA0,Tyr3]octreotate in Patients with Gastroenteropancreatic and Bronchial Neuroendocrine Tumors. Clinical Cancer Research. 23(16). 4617–4624. 416 indexed citations breakdown →

Kaloudi, Aikaterini, et al.. (2016). Improving the In Vivo Profile of Minigastrin Radiotracers: A Comparative Study Involving the Neutral Endopeptidase Inhibitor Phosphoramidon. Cancer Biotherapy and Radiopharmaceuticals. 31(1). 20–28. 23 indexed citations

Walrand, Stéphan, Glenn Flux, Mark Konijnenberg, et al.. (2011). Dosimetry of yttrium-labelled radiopharmaceuticals for internal therapy: 86Y or 90Y imaging?. European Journal of Nuclear Medicine and Molecular Imaging. 38(S1). 57–68. 53 indexed citations

Kwekkeboom, Dik J., Wouter W. de Herder, Boen L.R. Kam, et al.. (2008). Treatment With the Radiolabeled Somatostatin Analog [ ¹⁷⁷ Lu-DOTA ⁰ ,Tyr ³ ]Octreotate: Toxicity, Efficacy, and Survival. Journal of Clinical Oncology. 26(13). 2124–2130. 1093 indexed citations breakdown →

Müller, Cristina, Roger Schibli, Eric P. Krenning, & Marion de Jong. (2008). Pemetrexed Improves Tumor Selectivity of ¹¹¹In-DTPA-Folate in Mice with Folate Receptor–Positive Ovarian Cancer. Journal of Nuclear Medicine. 49(4). 623–629. 50 indexed citations

10.

Hoeben, Rob C., Martijn J. W. E. Rabelink, Leonard I. Wiebe, et al.. (2004). Molecular Imaging and Treatment of Malignant Gliomas Following Adenoviral Transfer of the Herpes Simplex Virus-Thymidine Kinase Gene and the Somatostatin Receptor Subtype 2 Gene. Cancer Biotherapy and Radiopharmaceuticals. 19(1). 111–120. 11 indexed citations

11.

Capello, Astrid, Bert F. Bernard, Mark Konijnenberg, et al.. (2004). Low-Dose-Rate Irradiation by ¹³¹ I Versus High-Dose-Rate External-Beam Irradiation in the Rat Pancreatic Tumor Cell Line CA20948. Cancer Biotherapy and Radiopharmaceuticals. 19(3). 285–292. 12 indexed citations

12.

Valkema, Roelf, Marion de Jong, Willem H. Bakker, et al.. (2002). Phase I study of peptide receptor radionuclide therapy with [111In-DTPA0]octreotide: The rotterdam experience. Seminars in Nuclear Medicine. 32(2). 110–122. 328 indexed citations

13.

Jong, Marion de, Roelf Valkema, François Jamar, et al.. (2002). Somatostatin receptor-targeted radionuclide therapy of tumors: Preclinical and clinical findings. Seminars in Nuclear Medicine. 32(2). 133–140. 260 indexed citations

14.

Sluis, Inge M. van der, et al.. (2000). Bone mineral density, body composition, and height in long-term survivors of acute lymphoblastic leukemia in childhood. Medical and Pediatric Oncology. 35(4). 415–420. 99 indexed citations

15.

Elhendy, Abdou, Jeroen J. Bax, Roelf Valkema, et al.. (1999). Dobutamine stress thallium-201 single-photon emission tomography versus echocardiography for evaluation of the extent and location of coronary artery disease late after myocardial infarction. European Journal of Nuclear Medicine and Molecular Imaging. 26(5). 467–473. 6 indexed citations

16.

Boot, Annemieke M., Sabine M.P.F. de Muinck Keizer‐Schrama, Huibert A. P. Pols, Eric P. Krenning, & Stenvert L. S. Drop. (1998). Bone Mineral Density and Body Composition before and during Treatment with Gonadotropin-Releasing Hormone Agonist in Children with Central Precocious and Early Puberty1. The Journal of Clinical Endocrinology & Metabolism. 83(2). 370–373. 77 indexed citations

17.

Docter, Roelof, Edith C. H. Friesema, Eric P. Krenning, et al.. (1997). Expression of Rat Liver Cell Membrane Transporters for Thyroid Hormone inXenopus laevisOocytes¹. Endocrinology. 138(5). 1841–1846. 29 indexed citations

18.

Reubi, Jean Claude, Eric P. Krenning, & Larry K. Kvols. (1996). Somatostatin Receptors in Gastroenteropancreatic Tumors. Digestive Surgery. 13(3). 161–169. 2 indexed citations

19.

Krenning, Eric P., Dik J. Kwekkeboom, Stanislas Pauwels, Larry K. Kvols, & Jean–Claude Reubi. (1994). The Role of Somatostatin Receptor Scintigraphy in Gastroenteropancreatic Endocrine Tumors. Digestive Surgery. 11(3-6). 456–460.

20.

Krenning, Eric P.. (1983). Thyroid hormone uptake by rat hepatocytes in primary culture. Data Archiving and Networked Services (DANS). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact